Haifa, Israel

Ori Farber

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: **Innovator Spotlight: Ori Farber and His Contributions to Tumor Treatment**

Introduction

Ori Farber, an inventive mind based in Haifa, Israel, is recognized for his significant contributions to medicine, particularly in cancer treatment technology. His innovative approach has paved the way for new methods in delivering tumor treating fields, showcasing the intersection of technology and healthcare.

Latest Patents

Farber holds a patent for a novel method and apparatus for delivering tumor treating fields to a torso. This invention outlines a procedure that involves precisely locating transducers on the subject's body—specifically, placing one transducer on the torso and another below it. The method aims to induce an electric field that optimally targets tumor cells, potentially improving treatment outcomes for patients battling cancer.

Career Highlights

As a key member of Novocure GmbH, a company focused on developing innovative cancer treatments, Ori Farber has leveraged his expertise to enhance the therapeutic options available for patients. His dedication to improving cancer therapies through technology has made a profound impact on the field.

Collaborations

Throughout his career, Farber has collaborated with talented individuals such as Ariel Naveh and Yoram Wasserman. These partnerships emphasize the importance of teamwork and collective experience in fostering innovation in the medical technology landscape.

Conclusion

Ori Farber's work exemplifies the vital role of inventors in advancing medical treatments. With his focus on technology-driven solutions to cancer, Farber continues to inspire others in the field, showcasing the power of innovation in improving patient care and outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…